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Abstract
Background: Activation of hepatic stellate cells (HSCs) plays an important role in the development of cirrhosis through the
increased production of collagen. p53, the ‘‘guardian of the genome’’, is a transcription factor that can bind to promoter
regions of hundreds of genes where it either activates or suppresses gene expression. Thereby, p53 serves as a tumor
suppressor by inducing cell cycle arrest, apoptosis, senescence and DNA repair. Artesunate is a derivative of Artemisinin,
Scholars had found it had more extensive pharmacological effects past 10 years. However, little is known about the
expression of p53 in the effects of Artesunate on induction of apoptosis and inhibition of proliferation in rat HSCs.
Methodology/Principal Findings: Isolated and cultured rat primary HSCs in the flask for 10 days to make cells activated.
HSCs were divided into two groups: experimental groups and control groups, experimental groups included with various
concentrations of Artesunate (125, 150, 175, 200, 225 mmol/L) for 24, 48 and 72 hours. Analysis of MTT revealed that
activated HSCs treated with various concentrations of Artesunate (150–225 mmol/L) were inhibited on dose and time-effect
relationships; Concentration of hydroxyproline in supernatant was detected by digestive method; Analysis of flow
cytometry demonstrated that Artesunate could arrest cell cycle in G1 and induce apoptosis; The nuclear morphological
changes in apoptotic cells were evaluated with DNA staining by Hoechst 33258 dye; The expression of p53 were up-
regulated showed by western blotting and RT-PCR.
Conclusion: Artesunate could inhibit HSCs proliferation in dose-dependent and time-dependent manners in vitro through
increase the expression of p53.
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Introduction
Liver fibrosis is a compensatory response to a variety of chronic
liver injury, is the hub of the development of ‘‘chronic hepatitis -
liver fibrosis – cirrhosis’’. At present, liver fibrogenesis is
considered a dynamic process involving complex cellular and
molecular mechanisms, resulting from the chronic activation of the
tissue repair mechanisms, which follows recurring liver tissue
injury. If the chronic damage persists, inflammation and fibrosis
can progress to liver cirrhosis, ultimately leading to organ failure
and death [1]. In the process of hepatic fibrosis, activation and
proliferation of hepatic stellate cells (HSCs) is the central link in the
incidence [2]. Hepatic stellate cells, also known as ‘‘Ito cells’’ or
‘‘fat-storing cells’’, localize between hepatocytes and sinusoids
(space of Disse) in mammalian livers. In their healthy state, HSCs
control retinoid homeostasis, sinusoidal blood flow, macromole-
cule transport, and potentially act as antigen-presenting cells in the
liver [3,4]. However, in response to hepatic injury, HSCs undergo
gross morphological and functional changes, transforming to a
myofibroblast-like phenotype in a process called ‘‘activation’’ or
‘‘trans-differentiation’’. Activated HSCs produce a number of
profibrotic cytokines and growth factors that perpetuate the
fibrotic process through paracrine and autocrine effects [5]. So
preventing HSCs activation and promoting HSCs apoptosis is an
important measure for prevention and treatment of liver fibrosis.
p53, the ‘‘guardian of the genome’’, is a transcription factor that
can bind to promoter regions of hundreds of genes where it either
activates or suppresses gene expression. Thereby, p53 serves as a
tumor suppressor by inducing cell cycle arrest, apoptosis,
senescence and DNA repair [6]. In normal cells, p53 is frequently
undetectable due to fast ubiquitination by mdm-2 and subsequent
proteasomal degradation. However, upon DNA damage and
several other stresses, including drug stress, the amount of p53 is
increased due to disruption of its degradation.
Artesunate is a derivative of Artemisinin. It had more extensive
pharmacological effects, such as anti-cancer [7], treatment of lupus
erythematosus [8] and anti-parasite [9]. But the standpoint that
Artesunate had anti-hepatic fibrosis effect was first proposed by
our group. In our previous studies, Artesunate could effectually
inhibit liver fibrosis in rats induced by carbon tetrachloride [10] or
immuned with bovine serum albumin [11], and proliferation of
HSC-T6 cell line [12]. But there has not been reported about the
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further approach the mechanism of Artesunate on anti-hepatic
fibrosis, in this study, we isolated and cultured rat primary HSCs,
observed the effects of Artesunate on proliferation, cell cycle,
apoptosis in cultured activated HSCs. We found that Artesunate
could inhibit HSCs proliferation in vitro through increase the
expression of p53.
Results
Hepatic stellate cells isolation , culture and identification
Freshly isolated rat HSCs were cultured on plastic in serum-
containing media. HSCs were observed by phase contrast
microscope and immunocytochemistry: HSCs isolated freshly
were spherical, had strong refraction and suspended in culture
medium (Figure 1A). After culturing for 10 days, HSCs were fully
spreading, presenting stellate or polygonal forms, lipid droplet in
the cells were significantly reduced (Figure 1B). The yield rate of
HSCs was (2–5)610
7 per rat liver,and the cell viability was more
than 95%. The flow cytometry analysis and the immunocyto-
chemical stain showed that the positive cells in freshly isolated
HSCs were 95.4% (Figure 1C) and more than 99% in passage
culture (Figure 1D, E, F, G).
Hepatic stellate cells growth curve
HSCs growth curve showed that the cultured HSCs were
proliferated after 72 h, turning into the logarithmic growth phase
on the 4th, 5th day and into the plateau phase on the 6th, 7th day
(Figure 2).
Artesunate inhibited HSCs proliferation
Results of MTT colorimetric showed that inhibition of HSCs
which cultured with different concentrations of Artesunate for 24,
48, 72 h significantly increased, compared with the control group
and the difference was statistically significant (P,0.01). In the
treatment groups stimulated for 24 h and 48 h, results showed that
the inhibitory effect increased with the concentration increasing
(P,0.01) and suggested that the inhibitory action of Artesunate on
HSCs proliferation was in a dose-dependent manner. In group
175 mmol/L, inhibition increased with time increaseing(P,0.01),
at 72 h, in group 150 mmol/L the inhibition rate reached 92.6%,
it suggested that inhibitory action of Artesunate on HSCs
proliferation was in a time-dependent manner (Table 1).
Artesunate decreased the concentration of
hydroxyproline in HSCs
After stimulated with Artesunate for 24 h, secretion of
hydroxyproline decreased in all experimental groups. Compared
with control group, the difference was statistically significant
(P,0.01) (Table 2).
Artesunate induced G1 phase cell cycle arrest in HSCs
In 175, 200 mmol/L groups, the percentage of cells at G0/G1
phase increased significantly (P,0.01), compared with the control
group, the percentage of S phase decreased significantly(P,0.05),
G2 / M phase cells did not obviously change (Table 3 and
Figure 3).
Artesunate induced apoptosis in HSCs
The results showed that the apoptotic HSCs induced by
Artesunate grew in number as the concentration increased.
Apoptotic rate of control group was (40.7360.81) %, rate of
treatment groups (concentration of Artesunate were 150, 175,
200 mmol/L, respectively) was (52.6360.84)%, (63.9760.50)%,
(66.6560.99)%. Compared with control group, the difference was
statistically significant (P,0.01) (Table 4 and Figure 4). Apoptotic
index increased with the increasing concentration of Artesunate,
and HSCs apoptosis induced by Artesunate exceeded spontaneous
apoptosis of HSCs.
Hoechst 33258 staining
Treatment with Artesunate, HSCs produced Hoechst-positive
staining of condensed nuclei that indicated apoptosis of the cells.
Significant increase in Hoechst staining was observed among
apoptotic HSCs treated with 175 mmol/L Artesunate (Figure 4),
which further indicated that Artesunate induced cell apoptosis.
Artesunate increased protein and mRNA levels of p53 in
HSCs
After HSCs acted by Artesunate 150, 175, 200 mmol/L,
respectively, for 24 h, western blotting and RT-PCR showed that
p53 was significantly increased, and with the increasing of drug
concentration (Figure 5, Figure 6).
Discussion
Hepatic stellate cells (HSCs), also known as Ito cells or fat-
storing cells, are mesenchymal cells mainly in the Disse space,
scattering the sinusoid wall. In normal liver, HSCs proliferate at a
very low rate, produce a small amount of extracellular matrix
(ECM) to maintain homeostasis of ECM production and
degradation. During the chronic liver injury, HSCs undergo a
process of transdifferentiation from a resting, fat-storing phenotype
to myofibroblasts which have a strong ability of proliferation, and
produce a large amount of ECM. The activated HSCs are major
source of hepatic ECM. Therefore, inhibition of HSCs prolifer-
ation and promotion of HSCs apoptosis are currently considered
to be effective treatment preventing the development of liver
fibrosis in chronic liver disease [13].
HSCs have some features of muscle cells, which contain desmin
in cytoplasm, and desmin stably present in the primary and
passaged HSCs. However, in normal rat liver, 50 percent of HSCs
around the central vein do not express desmin, and HSCs near
portal vein have high desmin staining positive rate. Thus, there
will be false negative if only desmin used as identification index.
Neubauer et al [14] found that glial fibrillary acidic protein
(GFAP) expressed in astrocytes was also expressed in HSCs.
Except the narrow area around periportal space, GFAP-positive
HSCs evenly distributed throughout the hepatic lobule, basically
complementary to the distribution of desmin. Therefore, in this
study, anti-desmin / FITC, anti-GFAP / TRITC, DAPI stain was
used to label desmin, GFAP and nuclei to improve the
identification accuracy. And HSCs can be distinguish from the
other cells in cell morphology, HSCs were larger, presents a
multiple corniform and typical star-shape pattern. In this study,
the result of identification showed that the purity of second
generation of HSCs has reached 99%. Artesunate is a partially-
synthetic derivative of artemisinin, which is extracted from the
Chinese herb Artemisia annua. Artesunate which has good water
solubility and high antimalarial activity is an important derivative
of artemisinin. Scholars found it had more extensive pharmaco-
logical effects past 10 years, such as anti-cancer, treatment of lupus
erythematosus, anti-parasite, anti-endotoxin and treatment of skin
diseases. From our previous experimental results, it can be seen
that Artesunate can inhibit proliferation of HSC-T6 cell line in
12.5 mg/mL–100 mg/mL, Artesunate (9.6 mg/kg, 28.8 mg/kg,
15 mg/kg orally) can significantly improve rat liver fibrosis
Effects of Artesunate on HSCs
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the basis of the effects of Artesunate on anti-hepatic fibrosis in vivo
and vitro, further investigating the effects of Artesunate on primary
cultured HSCs was completed. In this experiment, the MTT test
applied to explore the effective dose of artesunate on HSCs.
Beginning dose range from 100 mmol/L–100 mmol/L, step by
step to narrow dose range. Finally, we found that the sensitivity of
primary HSCs to artesunate is low. Results given by our
experiments showed that the inhibition of HSCs stimulated with
125 mmol/L Artesunate for 24 h rate was only 6.06%, while the
Artesunate concentration to 225 mmol/L, the inhibition rate
reached 79.83%. Through repeated tests and IC50 calculation,
ultimately, we identified 175 mmol/L as a middle concentration,
150 mmol/L and 200 mmol/L respectively as a low and high
concentration. The concentrations we chose were lower than the
concentration tested in vivo, we believe that this concentration is
feasible. However, in the latter part of the experiments, we found
that the differences between the three doses were constantly not
significant statistically, it may be due to the interval between three
doses were too small. In this study, Artesunate could significantly
inhibit proliferation of activated HSCs in vitro, and showed dose-
effect and time-effect relationships in 150–225 mmol/L. At the
same time, Artesunate decreased hydroxyproline in the superna-
tant, which suggested that Artesunate decrease production/
secretion of collagen.
We use p53 as a starting point in order to further explore the
mechanism of Artesunate inhibiting proliferation of HSCs from
the cell apoptosis and cell cycle. Apoptosis, or programmed cell
death is an active process of cell death controlled by genes to
regulate the body development, maintain homeostasis in multi-cell
organisms. Apoptosis is physiological regulatory mechanism of
internal environment, ensures the normal development of the
body by removing unnecessary or harmful cells by apoptosis, and
controls the number of cells of tissues and organs together with cell
division and proliferation. The previous study found that both
mitosis and apoptosis of HSCs were increased in liver fibrosis
process, especially proliferation. In reversal phase, apoptosis was
prevalent, and HSCs lost net increase. Apoptosis increased
collagenase activity, and promoted the degradation of ECM
which was conducive to the recovery of liver fibrosis. The results
Figure 2. Hepatic stellate cells growth curve. The second
generation of HSCs were collected and seeded in 96-well plates by
density of 5610
4/well, the absorbance was measured with microplate
reader ( l 570 nm), culture time as abscissa, absorbance value as
ordinate. HSCs were proliferated after 72 h, turning into the logarithmic
growth phase on the 4th, 5th day and into the plateau phase on the
6th, 7th day.
doi:10.1371/journal.pone.0026500.g002
Table 1. Inhibition rate of Artesunate on HSCs under
different concentrations and time (%,x6 s).
Group n Time (h)
24 48 72
control group 6 0.0060.00 0.0060.00 0.0060.00
125 mmol/L 6 6.0661.44 9.6164.82 75.5964.82
*&
150 mmol/L 6 21.4765.57
* 26.9769.28
* 92.6061.18
*&
175 mmol/L 6 42.0067.36
*# 70.5366.77
*#q 94.6160.90
*&
200 mmol/L 6 67.1264.55
*g 87.5562.40
*gq 94.9164.04
*
225 mmol/L 6 79.8363.67
* 94.9160.99
*q 95.3260.25
*
Compared with control group,
*P,0.01; compared with 150 mmol / L,
#P,0.01; compared with 175 mmol / L,
gP,0.01; compared with acted for 24 h,
qP,0.01; compared with acted for 48 h,
&P,0.01. Inhibition of HSCs which cultured with different concentrations of
Artesunate for 24, 48, 72 h significantly increased, compared with the control
group and the difference was statistically significant (P,0.01). In the treatment
groups stimulated for 24 h and 48 h, results showed that the inhibitory effect
increased with the concentration increasing (P,0.01) and suggested that the
inhibitory action of Artesunate on HSCs proliferation was in a dose-dependent
manner. In group 175 mmol/L, inhibition increased with time increasing
(P,0.01), at 72 h, in group 150 mmol/L the inhibition rate reached 92.6%, it
suggested that inhibitory action of Artesunate on HSCs proliferation was in a
time-dependent manner.
doi:10.1371/journal.pone.0026500.t001
Table 2. Effects of Artesunate on secretion of hydroxyproline
of HSCs (x6 s).
group N
Hydroxyproline content in supernatant
(mg/mL)
control group 6 1.71560.030
150 mmol/L 6 1.61960.026
*
175 mmol/L 6 1.51560.020
*
200 mmol/L 6 1.33960.030
*
Compared with control group,
*P,0.01.
doi:10.1371/journal.pone.0026500.t002
Figure 1. Hepatic stellate cells identification. A. Freshly isolated HSCs were spherical, had strong refraction and suspended in culture medium
(6100). B. 10-day primary cultured HSCs were fully spreading, presenting stellate or polygonal forms, granular cells were significantly reduced (6100).
C. Cell purity was detected by flow cytometry: freshly isolated HSCs stained by monoclonal anti-desmin and FITC-anti-IgG, and the the positive cells in
freshly isolated HSCs were 95.4%. D. Generation 2 HSCs were stained by DAPI: cell nucleus were stained and presented in blue (6600). E. Generation 2
HSCs were stained by GFAP/IgG-TRITC: positive cells were stained and presented in red (6600). F. Generation 2 HSCs were stained by desmin/IgG-
FITC: positive cells were stained and presented in green (6600). G. Generation 2 HSCs were stained by GFAP/IgG-TRITC , desmin/IgG-FITC and DAPI:
positive cells were stained and the number of HSCs more than 99% (6600).
doi:10.1371/journal.pone.0026500.g001
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dependent manner. After stimulating with different concentrations
of Artesunate for 24 h, Annexin V positive cells and Hoechst-
positive staining cells began to increase. The number of apoptotic
cells increased with increasing concentration of Artesunate.
Compared with the control group, the apoptosis rate of the
Artesunate groups (150, 175, 200 mmol/L) was significant
(P,0.01). It suggests one of key links of Artesunate anti-fibrosis
is induced apoptosis of HSCs, because apoptosis of the activated
HSCs means elimination of main source of ECM [15]. HSCs had
to be given to other laboratory for flow cytometry after marking
Annexin V and PI, as the delay on the way, there were more cells
appearing spontaneous HSCs apoptosis from the experimental
result. However, the overall trend of drug-induced apoptosis has
not changed, compared with the control group, there was
significant difference.
Program control of cell cycle is achieved mainly through orderly
phosphorylated and dephosphorylated of a variety of cell cycle
proteins (cyclin) and cyclin-dependent kinase (CDK) to control
activity of cyclin-CDK complex. The cellular transcription factor
p53 is involved in ‘‘growth arrest’’ and apoptosis [16]. It shows its
effects via repression or activation of other downstream genes and
is stimulated by either DNA damage or cellular stress events [17].
In a cell cycle, regulatory function of p53 is presented mainly in
monitoring calibration point of G1 and G2 / M phase, and is
Table 3. Effects of Artesunate on cell cycle of HSCs (x6 s).
group n G0/G1 S G2/M
control group 3 78.4860.44 17.9460.11 3.5860.42
150 mmol/L 3 79.0661.03 19.2360.80 1.7160.75
175 mmol/L 3 82.0960.06
* 15.3660.34
# 2.5560.31
200 mmol/L 3 83.1660.56
* 13.6261.95
* 3.2161.66
Compared with control group, **P,0.01,
*P,0.05.
doi:10.1371/journal.pone.0026500.t003
Figure 3. Effect of Artesunate on cell cycle of HSCs. A: control group; B: 150 mmol/L Artesunate group; C: 175 mmol/L Artesunate group;
D: 200 mmol/L Artesunate group. In groups 175, 200 mmol/L, the percentage of cells at G0/G1 phase increased significantly (P,0.01) , compared with
the control group, the percentage of S phase decreased significantly (P,0.05), G2 / M phase cells did not obviously change.
doi:10.1371/journal.pone.0026500.g003
Table 4. Effect of different concentrations of Artesunate on
HSCs apoptosis (x6 s, n=3).
group apoptosis rate(%)
control group 40.7360.81
150 mmol/L 52.6360.84*
175 mmol/L 63.9760.50*
200 mmol/L 66.6560.99*
*P,0.01.
doi:10.1371/journal.pone.0026500.t004
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reported the role of p53 protein in inhibition of cell proliferation,
such as p53 could induce arrest of cell cycle at G1 phase by acting
on p21 [18], p53 could arrest cell cycle at G1 phase by inhibiting
myc expression [19]. p53 was the ‘‘monitor’’ of cell growth, an
important negative regulator of cell growth. In this study, it is
confirmed that Artesunate could raise the level of p53 protein and
P53 mRNA, resulting in cell arrest and apoptosis [20]. Flow
cytometry showed that after treatment with Artesunate, there were
changes in the cell cycle: G0 / G1 phase cells increased, S phase
cells decreased, G2 / M phase cells was almost the same, it also
confirmed this view.
Overall, it was approved in our study that Artesunate could
directly inhibit the proliferation of primary HSCs by increasing the
expression of P53 mRNA and p53 protein, resulting in G1 arrest
and apoptosis. Artesunate plays an important role in anti-liver
fibrosis by inhibiting proliferation and promoting apoptosis of
HSCs to decrease production/secretion of collagen. It suggests
that Artesunate could be expected to be an ingredient of Chinese
medicine with anti-hepatic fibrosis effect.
Materials and Methods
Drugs and reagents
1. Drugs: Artesunate (C19H28O8), relative molecular mass 384.42,
provided by Guilin South Pharmaceutical Company Limited
(Guilin, Guangxi, CHN).
2. Main reagents: Dulbecco’s modified Eagle’s medium supple-
mented with 10% foetal bovine serum and antibiotics
(penicillin, 100 U/mL; streptomycin, 100 mg/mL) from Hy-
clone (Thermo, Beijing, CHN). Pronase E were purchased
from Roche Diagnostics GmbH (Roche, Mannheim, GER),
Figure 5. Effects of Artesunate on p53 contents in HSC (n=6).
After HSCs acted by Artesunate 150 mmol/L, 175 mmol/L, 200 mmol/L,
Compared with control group, the expression of p53 protein increased
significantly in Artesunate group, * P,0.05.
doi:10.1371/journal.pone.0026500.g005
Figure 4. Effects of different concentrations of Artesunate on HSCs apoptosis. A–D: Flow cytometric analysis: Apoptotic index increased
with the increasing concentration of Artesunate, apoptosis rate in the control group was (40.7360.81)%, apoptosis rates of treatment group
(artesunate concentrations were 150, 175, 200 mmol / L) were (52.6360.84)%, (63.9760.50)%, (66.6560.99)%, the difference was statistically
significant (P,0.01). However, HSCs have spontaneous apoptosis without the presence of artesunate. E–H: Hoechst 33258 staining showed apoptosis
was induced after Artesunate treatment. In Artesunate groups, nuclei appeared typical morphological changes of apoptosis, some appear condensed
chromatin state, a high degree of nuclear chromatin condensation, marginalization, and even serious cleavage fragments, resulting in apoptotic
bodies, and the nuclei of the normal control group without significant morphological changes, the nucleus shape rules, to issue uniform fluorescent.
A, E: control group; B, F: 150 mmol/L Artesunate group; C, G: 175 mmol/L Artesunate group; D, H: 200 mmol/L Artesunate group.
doi:10.1371/journal.pone.0026500.g004
Figure 6. Effects of Artesunate on P53 mRNA expression (n=6).
After HSCs acted by Artesunate 150 mmol/L, 175 mmol/L, 200 mmol/L,
Compared with control group, the expression of P53 mRNA increased
significantly in Artesunate group, * P,0.05.
doi:10.1371/journal.pone.0026500.g006
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MO, USA). Mouse antibody for human glial fibrillary acidic
protein (GFAP), goat antibody for mouse IgG-FITC, rabbit
antibody for rat desmin, goat antibody for rabbit IgG-TRITC
was purchased from Wuhan Boster Bio-engineering Limited
Company (Boster, Wuhan, CHN), hydroxyproline assay kit
purchased from Nanjing Jiancheng Biological Engineering
Institute(Jiancheng, Nanjing, CHN). Nuclear protein and
cytoplasmic protein extraction kit, high sensitivity ECL
chemiluminescence kit, HRP-labeled goat anti-mouse IgG
(H+L), b-actin antibody, Annexin V-FITC/PI kits and Beyozol
were purchased from Beyotime Institute of Biotechnology
(Beyotime, Haimen, CHN). Hoechst 33258 was purchased
from KeyGEN Biotech(KeyGEN, Nanjing, China). p53
monoclonal antibody was purchased from Invitrogen Corpo-
ration (Invitrogen, CA, USA). TransScript First-Strand cDNA
Synthesis SuperMix was purchaseed from TransGen Biotech
(Trans, Beijing, CHN). GeneRuler
TM 100 bp DNA Ladder
and DreamTaq
TM Green PCR Master Mix were purchased
from Fermentas Company(Fermentas, Shenzhen, CHN).
Primers P53 and PDGF were synthetized by Sangon Biotech
(Sangon, Shanghai, CHN).
Ethics Statement
All experimental protocols were approved by the Committee for
the Care and Use of Laboratory Animals of Tianjin, the permit
numbers is TJMU2009001.
Hepatic stellate cells isolation and culture
This method was improved on the basic method in reference to
Friedman [21]. Wistar rats of SPF grade were provided by
Laboratory Animal Center of the fourth institute of Military
Medical Science Academy of the PLA (Tianjin, China) and
maintained under 12:12-h light/dark cycles with food and water
ad libitum. Wistar rats of 300–400 g body weight were poodled
and disinfected with 75% (V:V) alcohol bath, ultraviolet
irradiation for 20 min, then ip heparin 50 U after intraperitoneal
injection of 25% urethane anesthesia(0.5 ml/100 g); HSCs were
isolated by sequential in situ perfusion with calcium-free perfusate
(142 mmol/L NaCl, 6.7 mmol/L KCl, 10 mmol/L HEPES,
5.5 mmol/L NaOH, pH 7.4) with heparin 4 U/mL, then
dissociation of integrated liver to Petri dish, ex vivo perfusion
with 50 ml 0.8 mg/mL pronase E, then circulating perfusion for
20 min with 50 ml 0.5 mg/mL type IV collagenase (prepared with
perfusate: 67 mmol/L NaCl, 6.7 mmol/L KCl, 5 mmol/L CaCl2,
100 mmol/L HEPES, 66 mmol/L NaOH, pH 7.6); the cell
suspension was centrifuged by discontinuity density gradient of
18%, 12% and 8% Nycodenz (1450 g/min, 20 min, 4uC). Taking
HSCs at 8% and 12% of the gradient interface, adjusting the cell
density to 5610
5/mL, seeding in culture flasks. Cells were grown
in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum with antibiotic. Culture medium was replaced
at day 2 after plating and then every 2–3 days. Cells were kept in
culture at 37uC in a 5% CO2 atmosphere and 100% humidity. For
all experiments, passages 2–4 of HSCs were used.
Hepatic stellate cells characterization
Morphology and growth characteristics of freshly isolated cells
were observed with inverted phase contrast microscope. The
purity of freshly isolated HSCs were analysed with flow cytometry
which all cells were stained by propidium iodide and HSCs were
stained by monoclonal anti-desmin / FITC-anti-IgG. The second
generation HSCs were stained respectively by anti-desmin /
TRITC- anti-IgG, monoclonal anti-GFAP/FITC-anti-IgG and
DAPI to identify the HSCs.
Hepatic stellate cells growth curve drawing
The second generation of HSCs were collected and seeded in
96-well plates by density of 5610
4/well. Incubated at 37uC, 5%
CO2 for 24, 48, 72, 96, 120, 144, 168 hours respectively. Then
10 ml MTT was added in each well, further incubated for 4 h.
150 ml DMSO was added in each well, absorbance (A) was
measured at l 570 nm on a microplate reader after a 10 min
vibrating. Absorbance in well with only added medium served as
control to zero setting. Growth curve was plotted, with culture
time as abscissa, absorbance value as ordinate.
MTT Assay for Cell Proliferation
The effects of Artesunate on cell proliferation were determined
by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay. 3610
3 cells/well were plated in 96-well culture
plates, cultured for 24 h, the cells were treated with various
concentrations of Artesunate (125, 150, 175, 200, 225 mmol/L) for
24, 48, 72 h. Control group (had been treated with vehicle only)
and each concentration group with six duplicate wells were set up,
the absorbance was measured with microplate reader ( l 570 nm).
Inhibition rate by the below formula (inhibition rate, IR) was
calculated, inhibition rate=[(A value of control group2A value of
experimental group) / A value of control group]6100%.
Hydroxyproline test in the cell culture supernatant
HSCs at logarithmic growth were seeded in 6-well plates by
density of 5610
5/mL. Treatment groups (respectively 150, 175,
200 mmol/L) and control group were set up. Culture supernatant
was collected after 24 hours, in which hydroxyproline was tested
according to instructions of the hydroxyproline assay kit.
Cell cycle analysis
HSCs at logarithmic growth were seeded in 6-well plates by
density of 5610
5/mL. Treatment groups(respectively 150, 175,
200 mmol/L) and control group were set up and cultured for
24 hours. HSCs were trypsinized, centrifuged (1000 r/min,
5 min), washed with cold PBS, fixed with cold 70% ethanol/
30% phosphate-buffered saline at 4uC overnight. HSCs were then
digested by 1000 U RNase A, and stained with 1% propidium
iodide at 37uC for 30 min. The DNA profiles were determined
within 4 h of staining by flow cytometry (Epcis ALTRA,
BECKMAN COULTER, USA). Data were analysed by EXPO32
(BECKMAN COULTER, USA). Fifteen thousand cells were
counted under each condition.
Effects of Artesunate on Hepatic stellate cells apoptosis
HSCs at logarithmic growth phase were seeded in culture flasks
by density of 1.5610
5/mL. Treatment groups (respectively
concentration of 150, 175, 200 mmol/L) and control group were
set up. Cells were collected after culturing for 24 h and detected by
flow cytometry (Epcis ALTRA, BECKMAN COULTER, USA)
according to the instructions of Annexin V FITC / PI kit. To
detect early apoptotic changes, staining with annexinV–fluorescein
isothiocyanate (FITC) was used, because of its known high affinity
to phosphatidylserine.
Phosphatidylserine is normally situated on the inner layer of the
plasma membrane. In the course of cell death, phosphatidylserine
is translocated to the outer layer of the membrane, this occurs in
the early phases of apoptosis, while the cell membrane itself
remains intact. In contrast to apoptosis, necrosis is accompanied
Effects of Artesunate on HSCs
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constituents into the environment. To distinguish apoptosis and
necrosis, propidium iodide, a common dye exclusion test, and
annexin V-FITC were used in parallel to show membrane
integrity after annexin V-FITC binding to cells.
Hoechst 33258 staining
HSCs at logarithmic growth were seeded in 96-well plates by
density of 1610
4/mL. Treatment groups (respectively 150, 175,
200 mmol/L) and control group were set up and cultured for
24 hours. HSCs were washed twice with PBS, then incubated with
2 mmol/L Hoechst 33258 for 15 min in dark at room tempera-
ture. HSCs were viewed under a fluorescence microscope (Nikon,
Tokyo, Japan) equipped with a UV filter. The images were
recorded on a computer with a digital camera (DXM 1200, Nikon)
attached to the microscope, and the images were processed by
computer. The Hoechst reagent was taken up by the nuclei of the
cells, and apoptotic cells exhibited a bright blue fluorescence.
Western blotting
HSCs at logarithmic growth phase were seeded in 6-well plates
by the density of 5610
5/mL. Treatment groups (respectively
concentration of 150, 175, 200 mmol/L) and control group were
set up. After culturing for 24 hours, cells were washed twice with
PBS, lysed by nuclear protein and cytoplasmic protein extraction
kit, and then nuclear protein content of the sample was
determinated by BCA protein determination kit. After quantifica-
tion, 20 mg of nuclear protein was taken, separated with 12%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). Protein separation was accomplished by 80 V for
2–3 h. Gels were then transferred at 120 mA for 1.5 h at
room temperature onto polyvinylidene fluoride membranes
(Immobilon-P
SQ, Millipore Corporation, MA, USA). Membranes
were blocked in blocking buffer consisting of 5% non-fat milk in
TBS-T (Tris-buffered saline Tween-20). Primary antibodies
against p53 diluted in blocking buffer at 1: 1000 were incubated
with the above PVDF membrane transferred by the proteins in gel
overnight at 4uC, followed by three washes. The b-actin antibody
as loading control was diluted at 1: 2000 overnight at 4uC also.
Membranes were incubated with horseradish peroxidase-conjugated
secondary antibodies for 2 h and then washed. Membranes were
colored with ultra-sensitive ECL chemiluminescence kit and film was
exposured. After developing and fixing, figure was scanned.
Densitometric evaluation of the blots was performed using the
program Image J.
Reverse-transcription PCR
Levels of mRNA for P53 were determined by RT-PCR. Total RNA
was isolated from cells using the Beyozol. cDNA was synthesized
according to Reverse Transcription kit manufacturer’s instructions, using
the following program: reverse transcription at 42uC for 30 min, 85uC
for 5 min, and then cDNA was amplified by DreamTaq
TM Green PCR
Master Mix according to manufacturer’s instructions. All amplifications
were run on a authorized thermal cycler, the amplification conditions
were one cycle at 94uC for 3 min, and then the PCR amplification was
performed for 30 cycles, consisting of denaturation (94uC, 30 s),
annealing [54uC, 1 min (or 55uC for GAPDH)], extension (72uC,
1 min), and an additional final extension step at 72uCf o r5m i n .P 5 3
expression levels were determined using the following primers:
59-GTTCCGAGAGCTGAATGAGG-39 (forward) and 59-TTTT
ATGGCGGGACGTAGAC-39 (reverse); primers for GAPDH: 59-
CGTCTTCACCACCATGGAGA-39 (forward) and 59-CGGCCAT-
CACGCCACAGTTT-39 (reverse). The expected sizes for the PCR
products: 125 bp for P53, 299 bp for GAPDH. The resulting PCR
products were separated by electrophoresis in a 2%-(w/v)-agarose gel in
TAE and stained with ethidium bromide. The mRNA levels were
calculated as the ratios of optical density of the PCR products to that of
the GAPDH PCR product using the program Image J.
Statistical treatment
Data were presented as mean 6 standard deviation (  x x6 s) , and
results were analysed using SPSS16.0 software, significance was
determined by one-way ANOVA.
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